Literature DB >> 9870258

Regulation of the preovulatory gonadotropin surge by endogenous steroids.

V B Mahesh1, D W Brann.   

Abstract

Estradiol secreted by growing ovarian follicle(s) has been considered classically to be the neural trigger for the preovulatory surge of gonadotropins. The observation that the estradiol-induced gonadotropin surge in ovariectomized rats is of lesser magnitude and duration than that found in the cycling rat at proestrus has resulted in a search for other steroid regulators. Progesterone is a major regulator of the preovulatory gonadotropin surge. It can only act in the presence of an estrogen background, which is necessary for the synthesis of progesterone receptors. In the estrogen-primed ovariectomized rat, progesterone is able to initiate and enhance the gonadotropin surge to the magnitude observed on the day of proestrus and limit it to 1 day. The physiological role of progresterone in the induction of the preovulatory gonadotropin surge has been demonstrated by the attenuation of the progesterone-induced surge and the endogenous proestrus surge by progesterone receptor antagonist RU486 and the progesterone synthesis inhibitor trilostane. The promoter region of the follicle-stimulating hormone (FHS)-beta gene contains multiple progesterone response elements and progesterone brings about FSH release as well. The reduction of progesterone in the 5 alpha-position appears to be important for the regulation of progesterone secretion. Corticosteroids appear to play a significant role in the secondary FSH surge on late proestrus and early estrus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9870258     DOI: 10.1016/s0039-128x(98)00075-0

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  26 in total

Review 1.  Multiple signal transduction pathways regulate ovarian steroidogenesis.

Authors:  Jennifer R Wood; Jerome F Strauss
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

Review 2.  Neuroendocrine dysfunction in PCOS: a critique of recent reviews.

Authors:  Suhail A R Doi
Journal:  Clin Med Res       Date:  2008-09

3.  Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome.

Authors:  S A R Doi; M Al-Zaid; P A Towers; C J Scott; K A S Al-Shoumer
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

Review 4.  Estradiol signaling in the regulation of reproduction and energy balance.

Authors:  Kevin Sinchak; Edward J Wagner
Journal:  Front Neuroendocrinol       Date:  2012-09-07       Impact factor: 8.606

5.  The naturally occurring luteinizing hormone surge is diminished in mice lacking estrogen receptor Beta in the ovary.

Authors:  Friederike L Jayes; Katherine A Burns; Karina F Rodriguez; Grace E Kissling; Kenneth S Korach
Journal:  Biol Reprod       Date:  2014-02-06       Impact factor: 4.285

6.  Rodent estrous cycle response to incomplete spinal cord injury, surgical interventions, and locomotor training.

Authors:  Prithvi K Shah; James Song; Samuel Kim; Hui Zhong; Roland R Roy; V Reggie Edgerton
Journal:  Behav Neurosci       Date:  2011-12       Impact factor: 1.912

Review 7.  Acute stress may induce ovulation in women.

Authors:  Juan J Tarín; Toshio Hamatani; Antonio Cano
Journal:  Reprod Biol Endocrinol       Date:  2010-05-26       Impact factor: 5.211

Review 8.  Neuroprogesterone: key to estrogen positive feedback?

Authors:  Paul Micevych; Kiran K Soma; Kevin Sinchak
Journal:  Brain Res Rev       Date:  2007-08-03

Review 9.  Physiology of membrane oestrogen receptor signalling in reproduction.

Authors:  P Micevych; J Kuo; A Christensen
Journal:  J Neuroendocrinol       Date:  2009-03       Impact factor: 3.627

10.  Oral progestin priming increases ovarian sensitivity to gonadotropin stimulation and improves luteal function in the cat.

Authors:  Rosemary A Stewart; Katharine M Pelican; Adrienne E Crosier; Budhan S Pukazhenthi; David E Wildt; Mary Ann Ottinger; JoGayle Howard
Journal:  Biol Reprod       Date:  2012-12-13       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.